Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240,356,213
-
Total 13F shares
-
75,864,626
-
Share change
-
+10,440,347
-
Total reported value
-
$836,285,496
-
Put/Call ratio
-
15%
-
Price per share
-
$11.08
-
Number of holders
-
138
-
Value change
-
+$117,532,707
-
Number of buys
-
90
-
Number of sells
-
44
Institutional Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q1 2024
As of 31 Mar 2024,
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) was held by
138 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,864,626 shares.
The largest 10 holders included
True Wind Capital Management, L.P., Clal Insurance Enterprises Holdings Ltd, MORGAN STANLEY, CROSSLINK CAPITAL INC, Nine Ten Capital Management LLC, Phoenix Holdings Ltd., ACADIAN ASSET MANAGEMENT LLC, Greenhaven Road Investment Management, L.P., Voss Capital, LLC, and ASHFORD CAPITAL MANAGEMENT INC.
This page lists
138
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.